Latest

UCSF

·August 23, 2023·5 min read

AI Revolution: Paralyzed Woman ‘Speaks’ via Digital Avatar

Researchers created a groundbreaking brain-computer interface (BCI) that allows a paralyzed woman to communicate through a digital avatar. This advancement marks the first-ever synthesis of speech or facial expressions directly from brain signals.

This shows an older man looking out a window.

Featured Neurology Neuroscience

·August 21, 2023·7 min read

Elderly People Who Live Alone at Increased Risk of Cognitive Decline

A startling study unveils a critical deficiency in the U.S. healthcare infrastructure: about 1 in 4 older Americans with dementia or cognitive impairments live solo, confronting increased hazards such as unsafe driving, medication mishaps, and overlooked medical appointments. This issue looms large, especially when juxtaposed against the backdrop of an aging demographic that's set to exponentially grow.

This shows the outline of a person in a DNA tunnel.

Featured Genetics Neuroscience

·July 19, 2023·6 min read

COVID-19 Super Dodgers: The Genetic Secret to Asymptomatic Infection

ertain individuals carry a unique gene variant that allows them to contract COVID-19 without displaying any symptoms. Dubbed as "super dodgers", these individuals are more than twice as likely to possess a mutation in a gene coding for human leukocyte antigen (HLA), a protein that aids virus-killing T cells to identify and annihilate SARS-CoV-2.

Featured Neurology Neuroscience

·July 17, 2023·5 min read

Donanemab: A Promising Step Forward in Early-Stage Alzheimer’s Treatment

A third new Alzheimer's drug, donanemab, is set for FDA approval, marking a significant step in slowing the progression of the disease. However, these treatments, which work best in the disease's early stages, may not suffice for patients with advanced Alzheimer's.

Featured Neurology Neuroscience

·June 13, 2023·5 min read

Antihistamine Sparks Hope for Myelin Repair in Multiple Sclerosis

A new study paves the way for potential treatments for Multiple Sclerosis (MS) by identifying the OTC antihistamine, clemastine, as an effective drug for brain repair. Utilizing a newly-developed MRI scan technique, scientists were able to observe and measure the impact of clemastine on brain myelin levels.

This shows the outline of a man and a brain.

Featured Neurology Neuroscience

·May 16, 2023·6 min read

Prolonged TCE Chemical Exposure Linked to 70% Increased Parkinson’s Risk

A new study reveals a significant link between long-term exposure to trichloroethylene (TCE) and a 70% increased risk of developing Parkinson's disease. Researchers compared Parkinson’s diagnoses in approximately 160,000 Navy and Marine veterans, half of whom were stationed at Camp Lejeune, where TCE contamination occurred.

Brain Cancer Featured Neurology Neuroscience

·May 12, 2023·6 min read

Common Seizure Drug Blocks Deadly Brain Cancer Growth

Researchers discovered a promising new avenue for treating glioblastoma, a deadly brain cancer. The study found that these tumors restructure connections in surrounding brain tissue, leading to cognitive decline. The team discovered that the drug gabapentin, commonly used to prevent seizures, could inhibit this activity in mice with glioblastoma.

Featured Neuroscience Psychology

·April 4, 2023·5 min read

Overwhelmed? Your Astrocytes Can Help With That

New research reveals a newly discovered brain circuit that involves astrocytes, a type of brain cell that tunes into and moderates the chatter between overactive neurons. This discovery could hold the key to treating attention disorders like ADHD, and sheds new light on how the brain processes information when overwhelmed.

Featured Neurology Neuroscience

·January 31, 2023·4 min read

Do Sleep Medications Increase Your Chances of Dementia?

People who frequently take sleeping medications are 79% more likely to develop dementia than those who never use sleeping pills to aid their rest.

Featured Neuroscience

·January 27, 2023·6 min read

Fresh Questions About Oxytocin as the ‘Love Hormone’ Behind Pair Bonding

The "love hormone" oxytocin may not play as critical a role in bonding as previously believed. Removing the oxytocin receptor in animal models still resulted in monogamous mating, attachment, and parental bonding behaviors, although females without the receptor produced milk in smaller quantities. Findings reveal parenting and bonding aren't purely dictated by oxytocin receptors.

Featured Genetics Neurology Neuroscience Open Neuroscience Articles

·January 25, 2023·4 min read

Drug That Targets Tauopathies in Mice Reveals Sex Differences in Response

Exposure to drugs that target tauopathies extended survival, reduced neurodegenerative biomarkers, and functionally reduced aberrant behaviors in female mice, but not in males.